References
- Bardwell A. J., Abdollahi M., Bardwell L. Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs. Biochem. J. 2004; 378: 569–577, [PUBMED], [INFOTRIEVE], [CSA]
- Bradley K. A., Mogridge J., Mourez M., Collier R. J., Young J. A. Identification of the cellular receptor for anthrax toxin. Nature 2001; 414: 225–229, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chopra A. P., Boone S. A., Liang X., Duesbery N. S. Anthrax lethal factor proteolysis and inactivation of MAPK kinase. J. Biol. Chem. 2003; 278: 9402–9406, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Collier R. J., Young J. A. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 2003; 19: 45–70, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cummings R. T., Salowe S. P., Cunningham B. R., Wiltsie J., Park Y. W., Sonatore L. M., Wisniewski D., Douglas C. M., Hermes J. D., Scolnick E. M. A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease. Proc. Natl. Acad. Sci. USA 2002; 99: 6603–6606, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dell'Aica I., Dona M., Tonello F., Piris A., Mock M., Montecucco C., Garbisa S. Potent inhibitors of anthrax lethal factor from green tea. EMBO Rep. 2004; 5: 418–422, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Duesbery N. S., Webb C. P., Leppla S. H., Gordon V. M., Klimpel K. R., Copeland T. D., Ahn N. G., Oskarsson M. K., Fukasawa K., Paull K. D., Vande Woude G. F. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998; 280: 734–737, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fridman M., Belakhov V., Lee L. V., Liang F. S., Wong C. H., Baasov T. Dual effect of synthetic aminoglycosides: antibacterial activity against Bacillus anthracis and inhibition of anthrax lethal factor. Angew Chem. Int. Ed. Engl. 2005; 44: 447–452, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gill D. M. Bacterial Toxins and Cell Membranes. Academic Press, London, New York 1978; 291–332
- Green B. D., Battisti L., Koehler T. M., Thorne C. B., Ivins B. E. Demostration of a capsule plasmid in Bacillus anthracis. Infect. Immun. 1985; 49: 291–297, [PUBMED], [INFOTRIEVE], [CSA]
- Hammond S. E., Hanna P. C. Lethal factor active-site mutations affect catalytic activity in vitro. Infect. Immun. 1998; 66: 2374–2378, [PUBMED], [INFOTRIEVE], [CSA]
- Kim J., Kim Y. M., Koo B. S., Chae Y. K., Yoon M. Y. Production and proteolytic assay of lethal factor from Bacillus anthracis. Protein Expr. Purif. 2003; 30: 293–300, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kim J., Chai Y. G., Yoon M. Y. Implication of pH in the catalytic properties of anthrax lethal factor. Biochem. Biophys. Res. Commun. 2004; 313: 217–222, [CROSSREF], [CSA]
- Kim J., Choi M. K., Koo B. S., Yoon M. Y. Development of high-throughput assay of lethal factor using native substrate. Anal. Biochem. 2005; 341: 33–39, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lee L. V., Bower K. E., Liang F. S., Shi J., Wu D., Sucheck S. J., Vogt P. K., Wong C. H. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides. J. Am. Chem. Soc. 2004; 126: 4774–4775, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Leppla S. H. Production and purification of anthrax toxin. Methods in Enzymology. Academic Press, London, New York 1998; 165: 103–116
- Levine L. M., Michener M. L., Toth M. V., Holwerda B. C. Measurement of specific protease activity utilizing fluorescence polarization. Anal. Biochem. 1997; 247: 83–88, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mikesell P., Ivins B. E., Ristroph J. D., Dreier T. M. Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect. Immun. 1983; 39: 371–376, [PUBMED], [INFOTRIEVE], [CSA]
- Min D. H., Tang W. J., Mrksich M. Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor. Nat. Biotechnol. 2004; 22: 717–723, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mock M., Fouet A. Anthrax. Annu. Rev. Microbiol. 2001; 55: 647–671, [CROSSREF], [CSA]
- Mock M., Roques B. P. Progress in rapid screening of Bacillus anthracis lethal factor activity. Proc. Natl. Acad. Sci. USA. 2002; 99: 6527–6529, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Morton N, Swartz M. D. Recognition and management of anthrax. N. Engl. J. Med. 2001; 345: 1621–1626, [CROSSREF], [CSA]
- Panchal R. G., Hermone A. R., Nguyen T. L., Wong T. Y., Schwarzenbacher R., Schmidt J., Lane D., McGrath C., Turk B. E., Burnett J., Aman M. J., Little S., Sausville E. A., Zaharevitz D. W., Cantley L. C., Liddington R. C., Gussio R., Bavari S. Identification of small molecule inhibitors of anthrax lethal factor. Nat. Struct. Mol. Biol. 2004; 11: 67–72, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pannifer A. D., Wong T. Y., Schwarzenbacher R., Renatus M., Petosa C., Bienkowska J., Lacy D. B., Collier R. J., Park S., Leppla S. H., Hanna P., Liddington R. C. Crystal structure of the anthrax lethal factor. Nature 2001; 414: 229–233, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Park J. M., Greten F. R., Li J. W., Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 2002; 297: 2048–2051, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Popov S. G., Villasmil R., Bernardi J., Grene E., Cardwell J., Wu A., Alibek D., Bailey C., Alibek K. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 2002; 293: 349–355, [CROSSREF], [CSA]
- Rivera V. R., Merrill G. A., White J. A., Poli M. A. An enzymatic electrochemiluminescence assay for the lethal factor of anthrax. Anal. Biochem. 2003; 321: 125–130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Salisbury C. M., Maly D. J., Ellman J. A. Peptide microarrays for the determination of protease substrate specificity. J. Am. Chem. Soc. 2002; 124: 14868–14870, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tawa P., Tam J., Cassady R., Nicholson D. W., Xanthoudakis S. Quantitative analysis of fluorescent caspase substrate cleavage in intact cells and identification of novel inhibitors of apoptosis. Cell Death Differ. 2001; 8: 30–37, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tonello F., Seveso M., Marin O., Mock M., Montecucco C. Screening inhibitors of anthrax lethal factor. Nature 2002; 418: 386, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tonello F., Ascenzi P., Montecucco C. The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited. J. Biol. Chem. 2003; 278: 40075–40078, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tonello F., Naletto L., Romanello V., Dal Molin F., Montecucco C. Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis. Biochem. Biophys. Res. Commun. 2004; 16: 496–502, [CROSSREF], [CSA]
- Turk B. E., Wong T. Y., Schwarzenbacher R., Jarrell E. T., Leppla S. H., Collier R. J., Liddington R. C., Cantley L. C. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 2004; 11: 60–66, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vitale G., Pellizzari R., Recchi C., Napolitani G., Mock M., Montecucco C. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 1998; 248: 706–711, [CROSSREF], [CSA]
- Vitale G., Bernardi L., Napolitani G., Mock M., Montecucco C. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 2000; 352: 739–745, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]